why am i not losing weight on retatrutide Working for Loss? Here's What to Check | PeptIQ Blog How Does Retatrutide Make You

The observed effects were consistent across subgroups and regardless of participants history of heart failure

Notably, only one registered clinical study exists to date, which evaluates an implant-based delivery system of Exenatide and is currently in Phase 1 with an Active, not recruiting status (NCT05670379), initiated on December 20, 2024, and expected to conclude by August 2025

& Lutz, T

Importantly, these analyses did not explore differential effects based on age, sex, and race/ethnicity of trial participants, so a high-risk subpopulation cannot be excluded

The timeline from final phase 3 completion to approval generally spans 1224 months, provided the data is strong and regulatory review is smooth

Lancet 394 , 131138 (2019) O